The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania

[1]  Till Bärnighausen,et al.  Sampling for Patient Exit Interviews: Assessment of Methods Using Mathematical Derivation and Computer Simulations , 2016, Health services research.

[2]  Dale A. Barnhart,et al.  Intra-cluster correlation estimates for HIV-related outcomes from care and treatment clinics in Dar es Salaam, Tanzania , 2016, Contemporary clinical trials communications.

[3]  T. Bärnighausen,et al.  Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness , 2016, AIDS.

[4]  S. Resch,et al.  Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study , 2016, BMJ Open.

[5]  R. Baltussen,et al.  Time and Money: The True Costs of Health Care Utilization for Patients Receiving “Free” HIV/Tuberculosis Care and Treatment in Rural KwaZulu-Natal , 2015, Journal of acquired immune deficiency syndromes.

[6]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[7]  S. Rosen,et al.  Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008–2013 , 2015, Journal of acquired immune deficiency syndromes.

[8]  Nakul P. Raykar,et al.  Geospatial mapping to estimate timely access to surgical care in nine low-income and middle-income countries , 2015, The Lancet.

[9]  W. Fawzi,et al.  Predictors of Nonadherence to Antiretroviral Therapy among HIV-Infected Adults in Dar es Salaam, Tanzania , 2015, Journal of the International Association of Providers of AIDS Care.

[10]  J. Lazarus,et al.  Health service delivery models for the provision of antiretroviral therapy in sub‐Saharan Africa: a systematic review , 2014, Tropical medicine & international health : TM & IH.

[11]  L. Morris,et al.  Clinical and virological response to antiretroviral drugs among HIV patients on first-line treatment in Dar-es-Salaam, Tanzania. , 2014, Journal of infection in developing countries.

[12]  B. Azuogu,et al.  Effects of nutrition counseling and monitoring on the weight and hemoglobin of patients receiving antiretroviral therapy in Ebonyi State, Southeast Nigeria , 2014, HIV/AIDS.

[13]  C. Kennedy,et al.  Barriers and facilitators of retention in HIV care and treatment services in Iringa, Tanzania: the importance of socioeconomic and sociocultural factors , 2014, AIDS care.

[14]  M. Siedner,et al.  Impact of Geographic and Transportation-Related Barriers on HIV Outcomes in Sub-Saharan Africa: A Systematic Review , 2014, AIDS and Behavior.

[15]  S. Jaffar,et al.  Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4+ cell counts: findings from a cluster-randomized trial , 2014, AIDS.

[16]  M. Giacomini,et al.  Chronic disease patients' experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis. , 2013, Ontario health technology assessment series.

[17]  C. Moyer,et al.  Drivers and deterrents of facility delivery in sub-Saharan Africa: a systematic review , 2013, Reproductive Health.

[18]  Karla Hemming,et al.  A Menu-Driven Facility for Sample-Size Calculations in Cluster Randomized Controlled Trials , 2013 .

[19]  S. Kaaya,et al.  Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative Study , 2013, PLoS medicine.

[20]  A. Alibhai,et al.  Antiretroviral Treatment for HIV in Rural Uganda: Two-Year Treatment Outcomes of a Prospective Health Centre/Community-Based and Hospital-Based Cohort , 2012, PloS one.

[21]  A. Alibhai,et al.  Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda , 2011, BMC international health and human rights.

[22]  S. Jaffar,et al.  Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study , 2011, AIDS research and therapy.

[23]  C. Pell,et al.  Social and Cultural Factors Affecting Uptake of Interventions for Malaria in Pregnancy in Africa: A Systematic Review of the Qualitative Research , 2011, PloS one.

[24]  Tania B. Huedo-Medina,et al.  Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis , 2011, AIDS and Behavior.

[25]  W. Tierney,et al.  Task-Shifting of Antiretroviral Delivery From Health Care Workers to Persons Living With HIV/AIDS: Clinical Outcomes of a Community-Based Program in Kenya , 2010, Journal of acquired immune deficiency syndromes.

[26]  P. Jones.  SSI: Stata module to estimate sample size for randomized controlled trials , 2010 .

[27]  S. Jaffar,et al.  Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial , 2009, The Lancet.

[28]  E. Wouters,et al.  Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome. , 2009, Social science & medicine.

[29]  Nneka Emenyonu,et al.  Transportation Costs Impede Sustained Adherence and Access to HAART in a Clinic Population in Southwestern Uganda: A Qualitative Study , 2009, AIDS and Behavior.

[30]  Till Bärnighausen,et al.  Human resources for treating HIV/AIDS: needs, capacities, and gaps. , 2007, AIDS patient care and STDs.

[31]  G. Meyer-Rath,et al.  User fees, transport costs, and the ethics of exemption: How free is free ART? , 2007 .

[32]  A. Hardon,et al.  Hunger, waiting time and transport costs: Time to confront challenges to ART adherence in Africa , 2007, AIDS care.

[33]  Julio S. G. Montaner,et al.  Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 109 cells/L , 2003, Annals of Internal Medicine.

[34]  R. Hogg,et al.  Virologic and Immunologic Response, Clinical Progression, and Highly Active Antiretroviral Therapy Adherence , 2002, Journal of acquired immune deficiency syndromes.

[35]  A. Zolopa,et al.  Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. , 2001, AIDS.

[36]  T. Bärnighausen,et al.  Time and money: the true costs of health care utilization for patients receiving 'free' HIV/TB care and treatment in rural KwaZulu-Natal. , 2015, Journal of acquired immune deficiency syndromes.

[37]  B. Stilwell,et al.  Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 revision. , 2006 .

[38]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .